The prognostic value of weight and body composition changes in patients with non-small-cell lung cancer treated with nivolumab

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)657-664
Number of pages8
JournalJournal of cachexia, sarcopenia and muscle
Issue number3
Publication statusPublished - Jun 2021


  • Non&#8208
  • small&#8208
  • cell lung cancer
  • Metastatic
  • Immune checkpoint inhibitors
  • Body composition changes
  • Weight changes
  • Overall survival

Cite this